Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Change in Inventory: 2011-2024

Historic Change in Inventory for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to -$2.7 million.

  • Adma Biologics' Change in Inventory rose 164.96% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year increase of 186.31%. This contributed to the annual value of -$2.7 million for FY2024, which is 127.75% down from last year.
  • As of FY2024, Adma Biologics' Change in Inventory stood at -$2.7 million, which was down 127.75% from $9.6 million recorded in FY2023.
  • Adma Biologics' Change in Inventory's 5-year high stood at $43.2 million during FY2021, with a 5-year trough of -$2.7 million in FY2024.
  • For the 3-year period, Adma Biologics' Change in Inventory averaged around $15.2 million, with its median value being $9.6 million (2023).
  • Its Change in Inventory has fluctuated over the past 5 years, first skyrocketed by 51.69% in 2021, then slumped by 127.75% in 2024.
  • Over the past 5 years, Adma Biologics' Change in Inventory (Yearly) stood at $28.5 million in 2020, then soared by 51.69% to $43.2 million in 2021, then declined by 10.73% to $38.6 million in 2022, then slumped by 75.03% to $9.6 million in 2023, then slumped by 127.75% to -$2.7 million in 2024.